We are live on ! Find out more
IMMP

Immutep

6 hedge funds and large institutions have $30K invested in Immutep in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,579% more capital inflows, than outflows

Capital inflows: $15.8K | Capital outflows: $940

20% more funds holding

Funds holding: 5 → 6 (+1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$12.2K
2
Citigroup
Citigroup
New York
+$626

Top Sellers

Rank Fund Capital Flow
1
Aperio Group
Aperio Group
California
-$689
2
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$251

IMMP Hedge Fund Activity: Q4 2014 in Review

6 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q4 2014, worth a combined $30K — down 23% from $39K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new IMMP positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $12.2K. The largest seller was Aperio Group, cutting an estimated $689.

  • 6 institutional investors held Immutep (IMMP) as of Q4 2014, up from 5 in Q3 2014.
  • Funds reported $30K of Immutep stock for Q4 2014, down 23% quarter-over-quarter.
  • 2 funds opened new Immutep positions in Q4 2014 and 0 closed out, a net change of +2 holders.
  • The largest Immutep buyer in Q4 2014 was Citadel Advisors, an estimated $12.2K added.
  • The largest Immutep seller in Q4 2014 was Aperio Group, an estimated $689 sold.

Based on aggregated 13F filings for Q4 2014.